Company Details
- Employees
- 16
- Founded
- -
- Phone
- 41227945085
- co****@****uro.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- geneuro.com
Please complete the CAPTCHA to continue
Related company profiles:
GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report Business Wire
GeNeuro Announces Approval of All Resolutions Proposed at Extraordinary General Meeting Yahoo Finance
GeNeuro SA Announces the Liquidation of Its French Subsidiary GeNeuro Innovation SAS Business Wire
GeNeuro SA Announces the Postponement of the Publication of the Company's 2024 Annual Results Yahoo Finance
Geneuro SA Postpones Publication Of Half-Yearly Financial Report TradingView
Geneuro SA postpones publication of half-yearly financial report MarketScreener
GeNeuro SA Announces the Extension of its Definitive Debt-Restructuring Moratorium Business Wire
GeNeuro SA Announces an Extraordinary Shareholders’ Meeting on June 30, 2025 Yahoo Finance
Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium TradingView
Geneuro SA announces extension of its definitive Debt Restructuring moratorium MarketScreener
GeNeuro's long COVID trial fails, triggering layoffs and search for strategic alternatives Fierce Biotech
Temelimab Proves Safe at Highest Dose for Multiple Sclerosis in Phase 2 Topline Data NeurologyLive
HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms Frontiers
SARS-CoV-2 induces human endogenous retrovirus type W envelope protein expression in blood lymphocytes and in tissues of COVID-19 patients medRxiv
Will GeNeuro SA (GEM) stock benefit from mergers - 2025 Price Action Summary & Free Real-Time Volume Trigger Notifications newser.com
GeNeuro secures EUR 5 million to advance post-COVID and neurodegenerative disease treatments Greater Geneva Bern area
Antibodies Against Viral Protein Tied to Better Survival Rate in ALS ALS News Today
SARS-CoV-2 induces human endogenous retrovirus type W envelope protein expression in blood lymphocytes and in tissues of COVID-19 patients medRxiv
GeNeuro's experimental multiple sclerosis drug shows hints it may help treat COVID-19 Fierce Biotech
Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis Labiotech.eu
Servier drops GeNeuro’s multiple sclerosis drug after midphase miss Fierce Biotech
1 +417920XXXXX
1 +33 4 3XXXXXXXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.